BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Plavix clopidogrel: Phase III data

Researchers at Beijing Tiantan Hospital and colleagues reported data from the double-blind, Chinese Phase III CHANCE trial in 5,170 patients showing that clopidogrel plus aspirin given within 24 hours after onset of minor ischemic stroke or transient ischemic attack met the primary endpoint...

Read the full 194 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >